Dr. Anil K D’Cruz is a highly respected senior oncologist consulting in Delhi with a focused clinical interest in the management of thyroid cancer. With over three decades of experience in oncologic care, he brings deep expertise in the evaluation, surgical treatment, and long-term management of thyroid malignancies, offering patients in Delhi access to nationally recognised clinical leadership.
He holds multiple prestigious qualifications, including MS, DNB, and FRCS, reflecting his commitment to advanced medical training and excellence in cancer care. At Apollo Athenaa Women’s Cancer Centre, Delhi, Dr. D’Cruz works closely with a multidisciplinary oncology team to ensure accurate diagnosis, evidence-based treatment planning, and comprehensive follow-up for patients with thyroid cancer.
Dr. D’Cruz is known for his patient-centric approach, combining precision surgical techniques, modern diagnostic support, and personalised care pathways. His clinical philosophy emphasises clear communication, informed decision-making, and compassionate support throughout the treatment journey. Fluent in English, Hindi, and Marathi, he is able to connect effectively with patients from diverse backgrounds.
As part of the Apollo oncology ecosystem in Delhi, Dr. D’Cruz contributes to a structured and collaborative model of care that integrates surgical oncology, endocrinology, pathology, radiology, and rehabilitation. His role at Apollo Athenaa strengthens the centre’s ability to deliver specialised thyroid cancer care with a strong focus on safety, outcomes, and long-term patient wellbeing.
Patients consulting Dr. Anil K D’Cruz in Delhi benefit from his extensive experience, methodical approach to thyroid cancer treatment, and commitment to delivering high-quality, ethical, and compassionate cancer care.
- Director - Oncology Apollo Hospitals, Mumbai, Chennai and Delhi
- Ex - Director of Tata Memorial Hospital and Chief of Head Neck Services
- Currently President Elect (2018-2020) and President (2020-2022) of the Union International for Cancer Control, Headquartered in Geneva. He is the first Indian to hold this position.
Memberships
- FOUNDATION HEAD AND NECK ONCOLOGY – GOVERNING COUNCIL MEMBER + PAST PRESIDENT
- ASIAN SOCIETY HEAD AND NECK ONCOLOGY – PAST PRESIDENT
- INDIAN SOCIETY ONCOLOGY
- ASSOCIATION OF SURGEONS OF INDIA
- INDIAN SOCIETY OF SURGICAL ONCOLOGY
Awards
Honorary FRCS from the Royal College of Surgeons London
President Elect (2018–2020) and President (2020–2022) of the Union International for Cancer Control, headquartered in Geneva. He is the first Indian to hold this position
Reseach & Publications
- Elective versus Therapeutic Neck Dissection in Oral Cancer
- Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer
- Elective versus therapeutic neck dissection in the clinically node negative early oral cancer: A randomised control trial (RCT)
- OP187. EARLY STAGE TONGUE CANCER WITH NODAL METASTASIS HAS A DISTINCT MOLECULAR SIGNATURE
- Predictors of prognosis for squamous cell carcinoma of oral tongue
- Relative value of ultrasound, computed tomography and positron emission tomography imaging in the clinically node-negative neck in oral cancer
- Organ preservation strategies: Review of literature and their applicability in developing nations
- Oral cancer: Review of current management strategies
- Ipsilateral neck nodal status as predictor of contralateral nodal metastasis in carcinoma of tongue crossing the midline
- Prospective study of 583 neck dissections in oral cancers: Implications for clinical practice
Your Questions Answered
Ask your query
Have a question? Ask your query below.

Best Hospital Near me Chennai